Torrent Pharmaceuticals share news, announcements and annual reports
NSE: TORNTPHARMBSE: 500420Pharmaceuticals & BiotechnologyLarge Cap
Torrent Pharmaceuticals Limited · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1994 on BSE, Nov 2002 on NSE
Last close ₹4,613.40up ₹33.40 (0.73%)BSE ₹4,635.15
Share price at the NSE close on 30 Oct 2026. Previous close ₹4,580.00.
30 Oct: open ₹4,560.00, high ₹4,672.00, low ₹4,532.00
52-week range of traded prices to 30 Oct 2026
₹3,532.60Low, 6 Nov 2025₹5,250.00High, 3 Aug 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,75,479 Cr61st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 82.62
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 9.55
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.82%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 15.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.76
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 4,36,64564.6% delivered
Torrent Pharmaceuticals share news and announcements
865 announcements, routine notices left out, newest first. Page 14 of 18.
Feb 2016
Jan 2016
22 Jan · Corporate action
Nov 2015
Oct 2015
21 Oct · News Verification
Exchange has sought clarification from Torrent Pharmaceuticals Limited, with respect to recent news item captioned "Torrent Pharma gets approval for generic version of Nexlum". In this regard, the Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.
Sep 2015
Jul 2015
28 Jul · Disclosure of Voting Pattern - Clause 35A
Jun 2015
May 2015
18 May · Corporate action
Share Transfer Books and Register of Members of the Company will remain closed from June 17, 2015 to June 19, 2015 (both days inclusive) for the purpose of final dividend for the year ended March 31, 2015, if declared by the Shareholders at the ensuing Annual General Meeting.18 May · Management
Smt. Bhavna Doshi, Independent Directors, has resigned from the Board of Directors of the Company with effect from the conclusion of the Board meeting held on May 15, 2015.15 May · Dividend
Board of Directors at their Meeting held on May 15, 2015 has recommended a final dividend of Rs. 6.25/- per equity share of Rs. 5/- each fully paid up further to the interim dividend of Rs. 5/- per equity share paid during the last quarter. These final dividend amounts, if declared by the Shareholders, are proposed to be paid / dispatched on or around July 31, 2015.
Apr 2015
15 Apr · News Verification
News Verification : The media had reports "Torrent eyes Encore derma biz for Rs. 350cr". The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Torrent Pharmaceuticals Limited has vide its letter inter-alia stated, "Kindly note that Torrent Pharmaceuticals Limited, does examine various opportunities for its growth, both organic and inorganic. Accordingly, the Company has submitted a Non-Binding Bid for one of the companies of Encore Group, subject to various assumptions and conditions and is in discussions for crystallizing the proposal. As such, we are not aware of any information that could have an impact on movement of the scrip."15 Apr · Legal
Exchange has sought clarification from Torrent Pharmaceuticals Limited with respect to recent news item captioned "Torrent eyes Encore derma biz for Rs. 350cr". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company are aware of any information that has not been announced to the Exchanges under clause 36 of the Listing Agreement. The response from the Company is awaited.
Mar 2015
31 Mar · Board meeting
Inter alia, to consider the Audited Financial Results for the year ended on March 31, 2015.
Feb 2015
Jan 2015
28 Jan · Board meeting
28 Jan · Dividend
Board of Directors of the Company in their meeting held on January 28, 2015 declared an interim equity dividend of Rs. 5.00 per equity share of Rs. 5.00 each fully paid up for the year 2014-15. The aggregate amount of interim equity dividend proposed to be distributed is Rs. 102 crores including tax on distributed profit of Rs. 17 crores.